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The frequent occurrence of pharmaceuticals in the aquatic environment requires an assessment of 
their environmental impact and their negative effects in humans. Among the drugs with high harmful 
potential to the environment are the antibiotics that reach the environment not only, as may be expected, 
through the effluents from chemical and pharmaceutical industries, but mainly through the sewage and 
livestock; because around 25 to 75% of the ingested drugs are excreted in unchanged form after the 
passage through the Gastro-Intestinal Tract. Tetracycline has high world consumption, representing a 
human consumption of about 23 kg/day in Brazil in 2007. At the moment, researches are being made to 
develop new tetracycline that incorporate heavy metals (Hg, Cd, Re, Pt, Pd) to their structures in order 
to increase their bactericidal effect. The conventional wastewater treatment plants are not able to degrade 
complex organic molecules to reduce their toxicity and improve their biodegradability. For this reason 
new technologies, i.e., the advanced oxidation processes, are being developed to handle this demand. The 
objectives of this study are to review the literature on the processes of obtaining tetracycline, presenting 
its waste treatment methods and evaluation of their environmental impact.
Uniterms: Tetracyclines/production. Tetracyclines/waste/tratament. Tetracyclines/waste/environmental 
impact. Environmental contamination. Domestic sewage/treatment. Industrial wastewater/treatment. 
Advanced oxidation processes/wastewater treatment.
A ocorrência frequente de fármacos no meio aquático exige a avaliação do seu impacto ambiental e seus 
efeitos negativos em seres humanos. Dentre os fármacos com maior potencial de impacto ambiental estão 
os antibióticos, que chegam ao meio ambiente através dos efluentes de indústrias químico-farmacêuticas 
e, principalmente, através de esgotos domésticos e criação de animais, visto que 25% a 75% dos fármacos 
são excretados em forma inalterada após passagem pelo Trato Gastrointestinal. Parcela significativa do 
consumo mundial dos antibióticos corresponde à classe das tetraciclinas, representando consumo humano 
de 23 kg/dia no Brasil, em 2007. Atualmente, há pesquisas de novas tetraciclinas que incorporam metais 
pesados (Hg, Cd, Re, Pt, Pd) às suas estruturas com o intuito de aumentar suas atividades bactericidas. 
As estações de tratamento de águas residuais convencionais não são capazes de degradar moléculas 
orgânicas complexas, diminuir a sua toxicidade e melhorar a sua biodegradabilidade. Por esta razão, as 
novas tecnologias, como, por exemplo, os processos oxidativos avançados, estão sendo desenvolvidos 
para lidar com esta demanda. Os objetivos deste trabalho são fazer uma revisão da literatura sobre os 
processos de obtenção de tetraciclinas, apresentar métodos de tratamento de seus resíduos e avaliar o 
seu impacto ambiental.
Unitermos: Tetraciclinas/produção. Tetraciclinas/resíduos/tratamento. Tetraciclinas/resíduos/impacto 
ambiental. Contaminação ambiental. Esgoto doméstico/tratamento. Efluentes industriais/tratamento. 
Processos oxidativos avançados/tratamento de águas residuais.
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INTRODUCTION
The main route of entry of pharmaceuticals in the 
environment is the release of domestic sewage, treated or 
untreated, into watercourses. However, we also must consider 
the effluents of pharmaceutical and chemical-pharmaceutical 
industries, rural effluents, and the presence of drugs in 
animal manure used for soil fertilization and improper 
disposal of expired products or unwanted drugs (Aga, 2008).
The world consumption of antibiotics has risen 
drastically in the last decade, also increasing the excretion 
of their metabolites in their original form. Most antibiotics 
are poorly metabolized by humans and animals after 
ingestion, providing that a fraction of antibiotics from 
25% to 75% may leave the bodies in an unaltered form 
after consumption (Khan, Ongerth, 2004; Watkinson et 
al., 2009; Rivas et al., 2011).
Tetracyclines, according Gu and Karthikeyan 
(2005), are the second group of antibiotics produced and 
more consumed worldwide.
They are considered to be safe drugs and have many 
favorable properties such as broad spectrum of activity, low 
toxicity, low cost, and it can, in most cases, be administered 
orally (Jeong et al., 2010). The most common side effects 
are nausea, vomiting and diarrhea. A unique constraint is 
for pregnant women and children during growth due to its 
deposition in bones and teeth calcification. Less common 
effects are induced photosensitivity, urticaria, headache, 
abdominal pain, hypertension, fever, mild leukopenia, 
anemia and thrombocytopenia. Patients who take insulin 
must be monitored, since tetracyclines may increase the 
persistence of insulin in the body, requiring more closely 
blood glucose levels monitoring in that patients (Zhanel et 
al., 2004).
Besides the use in humans, the tetracyclines are used 
in animal therapy to treat infections and promote growth. 
Oxytetracycline and chlortetracycline are two of the ten 
antimicrobials authorized in the United States as growth 
promoters for cattle (Jeong et al., 2010).
Tetracyclines are the third most consumed 
antibiotic, after penicillin and quinolones, and due to 
their indiscriminate use it has been detected an increasing 
number of bacteria resilient to tetracyclines (Pereira-Maia 
et al., 2010).
The phenomenon of resistance is indeed nowadays 
a great concern as there are strains resilient to almost all 
currently known agents (Rocha et al., 2011).
In this work is presented the processes of obtaining 
tetracycline, the treatment of their waste and the 
environmental impact assessment of waste containing 
tetracycline.
HISTORIC OF TETRACYCLINE
The discovery of the first member of the family 
of tetracyclines was in 1945 by Benjamin Duggar, and 
received the name of aureomycin (chlortetracycline), 
which is a product of natural fermentation of the bacteria 
Streptomyces aureofaciens, naturally present in the soil. 
Two years later, a second isolated tetracycline, terramycin 
called (oxytetracycline) was synthesized by the bacteria 
Streptomyces rimosus. In 1953, there was obtained the 
tetracycline molecule which has the simplest structure 
of this antibiotic family maintaining its functions. It was 
obtained through a biological process followed by a 
chemical process, which consisted in obtaining a precursor 
molecule by fermentation, followed by a chemical reaction 
for introducing of functional groups in the precursor 
molecule. It was observed that the basic structure of two 
antibiotics, aureomycin and terramycin, were the same, 
and the generic name tetracycline was suggested. After that 
many studies began to search for new tetracyclines (Pereira-
Maia et al., 2010; Sociedade Brasileira de Pediatria, 2012).
The three tetracycline antibiotics (tetracycline, 
oxytetracycline and chlortetracycline) were the basis for 
obtaining new derivatives in order to obtain less toxic 
drugs with better therapeutic use. Several byproducts were 
synthesized such as demeclocycline, rolitetracycline and 
the methacycline, which are considered first generation 
tetracyclines. An inconvenient of these antibiotics was 
the short time they could persist in the body, and it 
was overcome by the second generation tetracycline, 
doxycycline and minocycline (Sociedade Brasileira de 
Pediatria, 2012).
Thus, from 1950 to 1970, several members of 
the tetracycline family had been obtained, as natural 
or semisynthetic products, and in this same period, 
tetracyclines remained among the most commonly used 
antibiotics in the United States (Pereira-Maia et al., 2010).
PROPERTIES OF THE TETRACYCLINES
Tetracyclines constitute a large group of broad 
spectrum antibiotics obtained by fermentation of a specific 
bacteria Streptomyces aureofaciens e Streptomyces rimosus 
(tetracycline, chlortetracycline and oxytetracycline), 
semisynthetic processes (demeclocycline, rolitetracycline 
and methacycline) or synthetic (doxycycline and 
minocycline), with low molecular weight, good oral 
absorption and efficient hepatic excretion (Sociedade 
Brasileira de Pediatria, 2012).
It acts as inhibitor of protein synthesis by preventing 
the binding of aminoacyl-tRNA to the A site of the 
Tetracycline: production, waste treatment and environmental impact assessment 27
bacterial ribosome (Hasan et al., 1985).
All tetracyclines have the same spectrum and 
mechanism of action, adverse effects and similar 
tolerances by resilient organisms. However, they present 
some differences regarding pharmacokinetics (Sociedade 
Brasileira de Pediatria, 2012).
According to Pereira-Maia et al. (2010) the absolute 
configuration of the natural carbon atom C-4 is an essential 
requirement for the pharmacological action of these 
compounds. The presence of the amide grouping at C-2 
was also considered as a structural feature required for 
the biological action of tetracyclines. Another important 
observation related to increased enzyme inhibitory power 
was the absence of methyl groups and hydroxyl at position 
C-6. All these features are shown in Figure 1.
The pharmacokinetics for most tetracyclines is 
generally oral or parenteral, and is mainly absorbed in the 
stomach and upper small intestine (Pereira-Maia et al., 
2010). Tetracyclines have low metabolic rate, less than 
20% of the administered dose, i.e. more than 80% are 
eliminated mainly as unchanged through the intestinal 
tract (Regitano, Leal, 2010). Despite the similarity of 
metabolism of various representatives of the tetracycline 
family one of the main differences among the tetracyclines 
is their half-life in the body, which is presented below 
(Pereira-Maia et al., 2010; Regitano, Leal, 2010):
·	 doxycycline and minocycline are well absorbed by 
the body. They are long-acting drugs with long half-
-live greater than 15 h.
·	 demeclocycline action is a drug with an average 
half-life of 12 h.
·	 chlortetracycline, oxytetracycline and tetracycline 
are characterized by a poor absorption (25 to 30%), 
which is even smaller after food ingestion. They are 
considered active drugs with short half-life of 6 to 9 h.
Tetracyclines in the blood plasma are transported as 
calcium complex that once inside the cells of the bacteria, 
forms a complex with magnesium, which binds to the 
ribosome. In this regard, it is known that the binding of the 
ribosome complex magnesium inhibits protein synthesis 
by triggering the bacteriostatic effect (Rocha et al., 2011), 
which do not kill the microorganism, but acts as preventing 
bacterial multiplication and are eliminated by the defense 
system of the patient (Mathers et al., 2011).
In aqueous solutions, depending on the pH, three 
different groups within the molecule may undergo 
protonation or deprotonation (dimethylammonium, 
tricarbonylamide and phenolic diketone) (Zhao et al., 
2011a). Generally, tetracyclines, behave positive (pH 
<3.3), neutral (3.3 <pH <7.68) or negative (pH > 7.68) 
(Zhao et al., 2011b). The tetracyclines are strong chelating 
agents and pH dependent, and they have their antibacterial 
activity and pharmacokinetics decreased when associated 
with foods rich in calcium, iron, magnesium and other 
minerals or antacids such as sodium bicarbonate, which 
increase the pH in the stomach. Doxycycline has been 
an exception, because the ingestion of substances that 
increase gastric pH does not decrease its absorption 
(Pereira-Maia et al., 2010).
APPLICATION
Tetracyclines in normal use concentrations are 
FIGURE 1 - Relationship between the structure and activity of the molecule of tetracycline (Adapted from Pereira-Maia et al., 2010).
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bacteriostatic, helping the inhibition of protein synthesis 
by binding to the 30S fraction of the bacterial chromosome 
by preventing the attachment of tRNA, interfering with the 
supply and connecting the amino acids forming proteins. 
In higher concentrations they can exercise bactericidal 
effect.
In general, the more lipophilic molecules are more 
active than the hydrophilic due to their interaction with 
lipoprotein in biological membranes. Tetracycline have 
the ability to cross the cell membrane by passive diffusion 
process and by active transport due to its good diffusion 
inside the cells and therefore exhibit excellent antibiotic 
activity against intracellular bacteria (Zhanel et al., 2004; 
Sociedade Brasileira de Pediatria, 2012).
They are usually indicated for infections whose 
agents are Rickettsia, Chlamydia, Mycoplasma and 
Borrelia, Campylobacter, Ureaplasma urealyticum and 
Legionella. They are effective in treating spotted fever, 
epidemic typhus, Q fever and other rickettsial diseases. 
They also act on psittacosis, Lymphogranuloma venereum 
caused by the chlamydia; in atypical pneumonias caused 
by Mycoplasma pneumoniae. They have action in 
the treatment of brucellosis, tularemia, bartonellosis, 
actinomycosis, recurrent fevers, cholera. They are 
indicated for penicillin-allergic patients and patients with 
gonorrhea. They can be used for infections caused by 
group A Streptococcus, Staphylococcus, Pneumococcus, 
Gram-positive and Gram-negative and espiroquetoses 
and as second choice in the treatment of Plasmodium 
falciparum malaria, amebiasis by the Entamoeba 
histolytica, peptic ulcers caused by Helicobacter pylori 
and the treatment and prevention of bacteria used as 
biological weapons in terrorism such as anthrax (Cox, 
Popken, 2010; Pereira-Maia et al., 2010; Mathers et al., 
2011; Sociedade Brasileira de Pediatria, 2012).
In relation to the pharmacological properties of 
these compounds, they possess a number of non-antibiotic 
properties and several studies have been conducted to use 
tetracyclines in the treatment of non-infectious diseases 
such as rheumatoid arthritis and cancer (Regitano, Leal, 
2010; Mathers et al., 2011).
Mathers et al. (2011) presented several studies on 
various mechanisms for non-antibiotic tetracyclines, 
such as the control of inflammation, inhibition of tumor 
progression, bone resorption, angiogenesis and stroke due 
to inhibition of protein kinase C and metalloproteinases, 
the inhibition of nitric oxide synthase, leading to non-
production of nitric oxide, which is responsible for 
the classic inflammatory symptoms in osteoarthritis, 
rheumatoid arthritis, systemic lupus erythematosus, 
ulcerative colitis and Crohn’s disease, exerting effects 
“chondro protective” prophylactic effects of treatment 
of acne, wound healing and inhibition of collagen gel 
contraction by myofibroblasts.
The main advantage of the antineoplasic action 
of tetracyclines (especially doxycycline) is compared 
to greater tolerance with increasing dose of the drug, 
allowing the synergistic treatment with drugs such as 
cisplatin, currently used in lower doses, while maintaining 
the efficacy of the treatment (Pereira-Maia et al., 2010).
CONSUMPTION IN LATIN AMERICA
Wirtz et al. (2010) used the studies presented by the 
World Health Organization (WHO) in the period 1997 to 
2007 to evaluate in the consumption of antibiotics in eight 
Latin American countries. The results reported by WHO 
were based on national sales of antibiotics for the retail 
(direct sales in private pharmacies and indirect sales in 
private clinics and hospitals), not providing information 
of antibiotics purchased by the public sector (government 
contractors).
Figure 2 shows the daily consumption of various 
antibiotics consumed in many Latin American countries 
in 2007.
According to data provided by Wirtz et al. (2010) 
and Brazilian population estimates for the year 2007, we 
can say that tetracyclines are the third most consumed 
antibiotics in Brazil, after penicillin and quinolones, 
representing 23 kg/day for human consumption.
Little information about the dispensing of antibiotics 
is offered in existing bibliographies, especially in 
developing countries, where control is still very deficient 
FIGURE 2 - Use of antibiotics in eight Latin American countries, 
by therapeutic class in the year 2007 (Adapted from Wirtz et 
al., 2010).
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(Díaz-Cruz and Barceló, 2007). However, it is estimated 
that more than 70% of such compounds are antibiotic 
agents (Thiele-Bruhn, 2003).
In a more recent estimate (Kools et al., 2008) about 
4.6 million kilos of antibiotics were used for animal 
production in the countries of the European community, 
and tetracyclines, the β-lactams and cephalosporins were 
the most consumed products.
In Brazil, in general, there are no statistics about 
the amount of antibiotics sold for animal production. 
The Ministry of Health of Paraná, in 2005, conducted a 
qualitative study on the marketing of veterinary medicines 
in broilers, where groups of preventive medications most 
frequently cited were fluoroquinolones (34%), ionophores 
(20%), macrolides (10%), quinolones, tetracyclines 
(6%), sulfonamides (4%), lincosamides (3%). The 
most cited therapeutics already cited were ionophores 
(25%), fluoroquinolones (19%), sulfonamides (14%), 
tetracycline (11%), β-lactams (7%), macrolides (5%) and 
aminoglycosides (4%). This same survey also found some 
irregularities such as the use of tetracyclines, tiamulin, 
ciprofloxacin, norfloxacin and enrofloxacin as growth 
promoters, which are prohibited by the Ministério da 
Agricultura, Pecuária e Abastecimento (MAPA) (Regitano 
and Leal, 2010).
According to Pereira et al. (2012), it is estimated 
that in the year 2009, the sale of antibiotics for veterinary 
use in Brazil with the most varied purposes (therapeutic, 
preventive or growth promoter) was about US$ 379 
million.
BACTERIAL RESISTANCE MECHANISMS
In Table I are shown some results of the in vitro 
activity of four tetracyclines for Gram-negative and Gram-
positive bacteria with relevance in medical clinic. Table I 
shows the minimum drug concentration required to inhibit 
90% of growth of the bacteria (MIC90) (Pereira-Maia et 
al., 2010).
Interestingly, a study by Mathers et al. (2011) 
showed that only 20% of the Escherichia coli present 
in human intestine was resistant to tetracycline before 
the treatment of acne. In the same study was shown that 
resistance was increased to 96% after 10 weeks of use of 
the antibiotic (500-1000 mg/day).
Two mechanisms of clinical significance are 
primarily responsible for bacterial resistance to 
tetracyclines:
·	 Removing active antibiotics from the cell through 
the mechanism known as efflux pumps, causing 
TABLE I - In vitro activity of tetracyclines in selected organisms (Pereira-Maia et al., 2010)
Bacteria
Tetracycline Doxycycline Minocycline Tigecycline
MIC90 (mg/L)
Gram-positive
Staphylococcus aureus (MS) 1 0.5 0.12 0.5
Staphylococcus aureus (MR) 32 2 2 0.5
Streptococcus pneumoniae (PS) 32 8 8 0.125
Streptococcus pneumoniae (PR) 64 8 16 0.125
Enteroccocus faecalis 128 16 32 0.25
Enteroccocus faecium 64 16 16 0.25
Gram-negative
Haemophilus influenza 0.5 3.1 0.25 1
Haemophilus influenza (BLP) 1 ND 1 2
Klebsiella pneumoniae 4 ND 4 1
Neisseria gonorrhoeae (PS, PR) >32 2 32 1
Escherichia coli >8 ND 8 0.5
Atypical organisms
Chlamydia pneumoniae ND 0.25 ND 0.125
Legionella pneumophila 1-8 4 4 ND
Mycoplasma pneumoniae 1 1.6 1 0.25
ND = not determined
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the antibiotic to be quickly pumped out of the cell. 
In case the tetracycline efflux occurs through trans 
membrane proteins (Tet A) exporting the molecule 
complexed with Mg2+, [MgTc]+ out of the cell, le-
ading to a lower concentration of drug within the 
bacterial cells (Depizzol, 2006; Pereira-Maia et al., 
2010).
·	 The ribosomal protection through cytoplasmic pro-
teins that protect the ribosome from the action of 
tetracyclines (Pereira-Maia et al., 2010).
Both mechanisms enable protein synthesis proceed 
normally. Figure 3 outlines the mechanism of bacterial 
resistance to efflux mechanism.
COORDINATION OF METALS
Recently, several research groups have shown 
that antibiotics containing metal complexes are often 
more active than the parent compound. The coordination 
platinum (II) to tetracycline and doxycycline through the 
ring A, shown in Figure 1, results in active compounds 
against bacterial strains resistant to tetracycline and other 
antibiotics (Pereira-Maia et al., 2010; Rocha et al., 2011).
Some metal complexes are found in several articles 
presented in the work by Pereira-Maia et al. (2010) and 
are shown in Table II.
The palladium complex coordinated to tetracycline 
is sixteen times more potent than the free drug. The 
coordination of palladium to doxycycline also increases 
the activity on resistant strains of bacteria, the complex 
being two times more potent than the free drug (Rocha et 
al., 2011). Table III shows the values of concentration of 
each compound required to inhibit 50% of cell growth.
The coordination of antibiotic metal ions has been 
used not only as a mechanism for reversing resistance, but 
also as a strategy for developing new drugs, particularly 
those with activity in the treatment of tumors, studies for 
directing a new set of substances similar as the Chemically 
Modified Tetracyclines known as CMTs. The removal 
of the dimethylamino group in C11 position (Figure 
1) eliminates the antibacterial action and potentiates 
side effects. The chemotherapeutic action occurs 
through inhibition of enzymes known as MMP (matrix 
metalloprotease), focusing in prevention of angiogenesis 
and metastasis (Pereira-Maia et al., 2010; Rocha et al., 
2011).
Despite several trials in developing these modified 
molecules, their introduction in the market should be 
carefully evaluated because the bioaccumulation of a 
TABLE II - Metal complexes as binders using tetracycline (Pereira-Maia et al., 2010)
Reagents and stoichiometry Solvent pH Product obtained Coordination site
LnCl3 + TC.HCl MeOH 7.0 [Ln(TC)Cl3].2H2O O6, O7 e O15
NiCl2.6H2O + 2.1 TC.HCl MeOH 7.5 [Ni(TC)2(H2O)2] Oxygens - ring A
CoCl2.6H2O + 2.2 ATC.HCl MeOH 8.0 [Co(ATC)2(H2O)2] Oxygens - ring A
K2PdCl4 + TC.HCl H2O NF [Pd(TC)Cl2].2H2O O12 e Oamide
K2PtCl4 + TC.HCl H2O NF [Pt(TC)Cl2] O12 e Oamide
* K2PtCl4 + 4.1 TC Acetic acid NF [Pt(ATC)Cl2] Ring A
K2PtCl4 + DOX.HCl H2O NF [Pt(DOX)Cl2].2H2O O12 e Oamide
* Re(CO)Cl + OTC.HCl Toluen NF [Re(OTC)(CO)3Cl] O6 e O7
** 1.4 Cu(ClO4)2 + 2.5 TC EtOH- Teof NF [Cu(TC)2(ClO4)2] O12 e Oamide
** 1.4 Fe(ClO4)3 + 2.5 TC EtOH- Teof NF [Fe(TC)2(ClO4)3] O12 e Oamide
*** HgCl2+ OTC H2O- MeOH NF [Hg(OTC)Cl2].2H2O O12 e Oamide
* Reaction made at 70 °C. ** Reaction made between 40-50 ºC. *** Crystals obtained at 8 ºC. Ln = Lanthanides in general, 
Teof = Triethyl orthoformate, NF= pH not fixed. The coordination sites are shown in Figure 1.
FIGURE 3 - Schematic diagram representing the efflux 
mechanism of bacterial resistance (Adapted from Pereira-Maia 
et al., 2010).
Tetracycline: production, waste treatment and environmental impact assessment 31
TABLE III - IC50 values for complexes of palladium (Pd) and 
platinum complexes (Pt) (Rocha et al., 2011)
Compound IC50 (µM)
Doxycycline 17.7
Tetracycline 52.37
Complex of Pd2+ with tetracycline 34.54
Complex of Pd2+ with doxycycline 14.14
Complex of Pt2+ with doxycycline 6.3
Complex of Pt2+ with tetracycline 9.39
IC = inhibitory concentration
metal ion can cause severe side effects. Therefore, their 
pharmacological and physiological actions must be studied 
in vivo, in animals, before their use in human clinic tests 
(Rocha et al., 2011).
OCCURRENCE IN THE ENVIRONMENT
Residues of antibiotics, including tetracyclines from 
Wastewater Treatment Plants (WWTPs) of urban and 
agricultural effluents are frequently detected in surface 
water, groundwater, soils and sediments (Zhao et al., 
2011b).
The antibiotics oxytetracycline and doxycycline are 
commonly detected in aquatic environment and WWTPs 
effluents (Yuan et al., 2011). Generally, they are present in 
relatively low concentrations (ng or mg per L), below the 
threshold levels to show the effects of medicinal treatment 
on bacterial populations and other exposed species (Boxall 
et al., 2003; Zhao et al., 2011b).
The existing literature is restricted almost entirely 
to works developed in environment temperate conditions 
(Regitano, Leal, 2010).
The use of animal excreta and sewage sludge as 
fertilizers are major routes of spread of these compounds 
in the environment (Regitano and Leal, 2010). The final 
disposition of these effluents in rivers and agricultural use 
of sewage sludge or organic fertilizers are an important 
source of environmental exposure to wide range of 
pharmaceuticals for humans and animals (Kim et al., 
2007).
The environmental destiny and behavior presented 
by drugs contained in several sources are influenced 
by a variety of factors, including the physicochemical 
properties of the molecule, properties of the soil and 
of the environmental conditions (Kemper, 2008). 
Tetracyclines have low potential for mobility in soil due 
to its high potential for adsorption (KD = 70-5000 L/kg) 
(Tolls, 2001; Regitano, Leal, 2010). Typical examples of 
tetracyclines in the environment are the chlortetracycline 
and oxytetracycline, which have a high potential for 
dissemination in the environment due to their use in 
animal intensive farming and aquaculture, where the 
administration is primarily topically or orally. The 
metabolism in the animal organism is usually low (Boxall 
et al., 2003).
Antibiotics with half-life (t1/2) of permanence in 
environment more than 60 days are considered very 
persistent, while those compounds exhibiting t1/2 longer 
than 14 days may present environmental problems due to 
leaching (Regitano and Leal, 2010).
Several studies on the adsorption of tetracyclines 
in relation to the adsorbent matrix components are given 
below.
Sassman and Lee (2005) investigated the main 
mechanism involved in cation exchange and adsorption 
potential. They observed that pH influenced the cation 
exchange capacity of the predominant minerals in the 
soil matrix.
Thiele-Bruhn (2003) observed that the highest 
potential adsorption occurred in the presence of cations 
of higher valency (Ca2+ instead of Na+, for example) 
due to complex formation between the tetracycline and 
multivalent cations.
Zhao et al. (2011a,b) studied five cations (Li+, Na+, 
K+, Ca2+ and Mg2+) with concentration of 0.01 M and 
observed that they exhibited little effect on the adsorption 
of tetracycline in the pH range between 3 and 10. Cations 
of heavy metals such as Cu2+ and soil organic matter 
(humic acid) exhibited a high effect on the mobility of 
tetracyclines in the soil, affecting their concentration and 
toxicity to organisms.
Gu and Karthikeyan (2005) investigated the 
interaction of tetracycline with iron oxide and hydrated 
aluminum oxide. Spectroscopic analysis showed that 
carbonyl groups tricarbonylamide may be responsible for 
the adsorption on minerals in clay soil.
Hellweger et al. (2011) claimed that environmental 
concentrations of tetracycline in surface waters are 
usually less than 0.11 mg/L, although higher values of 
up to 6.8 mg/L have been observed. The MIC values are 
approximately 3.000 mg/L for clinical pathogens and 
2000 mg/L for isolates from environmental bacteria. 
The concentration truly dissolved can be estimated 
from data equilibrium between phases presented in their 
work, involving a variety of mechanisms (e.g. cation 
exchange).
Table IV presents the results of occurrence of 
tetracycline in the environment.
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DAMAGES TO THE LOCAL BIOTA
Actually little is known about the problem of eco-
toxicity promoted by prolonged exposure to low doses 
of antibiotics, as well as the impacts caused by unknown 
metabolites in the aquatic environment, since they can also 
exhibit biocide action, as observed for the degradation 
products enrofloxacin and tetracycline, as it is unclear 
which organisms are affected and to what degree (Bila 
and Dezotti, 2003; Sarmah et al., 2006).
Standard studies involving organisms have 
demonstrated in vitro that the occurrence of environmental 
parameters does not exhibit acute effect on the test 
organisms. Wollenberger et al. (2000) evaluated the acute 
and chronic toxicity of oxytetracycline, tetracycline, 
sulphadiazine and tylosin in Daphnia magna. Those 
authors found no toxic effects in environmentally relevant 
concentrations; however they observed toxic effects caused 
by the chronic exposition to high concentrations (5 to 
50 mg/L) of oxytetracycline, tetracycline and sulphadiazine.
Kümmerer (2009) evaluated the toxicity of 
tetracycline, ampicillin, chloramphenicol and streptomycin 
to the species Vibrio harveyi. They found no toxic effects 
for long term tests and for concentrations usually found in 
the environment. However, they observed a reproduction 
decrease for the same conditions tested before.
Another relevant factor is related to bioaccumulation 
in organisms, this process is governed mainly by the 
lipophilic character of the molecule, which can be 
expressed by the partition coefficient n-octanol-water 
(Kow) usually expressed in logarithmic form (Regitano 
and Leal, 2010).
Kim et al.  (2012) verified the influence of 
tetracycline concentration (0.1 to 5.0 mg/L) on the 
fecundity (time to first reproduction and number of births 
per female), longevity, morphological structure (size 
and weight) and growth in four generations of Daphnia 
magna. Through this study that authors observed that the 
reproduction and the number of descendants decreases 
with increasing concentration of tetracycline to each 
subsequent generation. On the morphological structure 
observed increased weight and size, probably due to the 
decreased reproduction due to the targeting of energy for 
the development of the structure. Organic molecules with 
values of log Kow>4.0 tend to accumulate in lipid tissues 
(Curi et al., 2003).
According to Regitano and Leal (2010), with regard 
to antibiotics, it can be said that:
TABLE IV - Environmental concentration of antibiotics of the tetracycline family 
Antibiotic Mean concentration (µg/L) Matrix Country
Chlortetracycline
0.15(1) Surface water USA
0.42(2) Natural water USA
up to 0.69(3) Surface water UK
0.9(4) Water UK
4.6 – 7.3 (µg/kg) (1) Soil (0-30 cm) North Germany
41.8 (µg/kg) (4) Soil UK
up to 46 (mg/kg) (1) Swine manure Austria
Oxytetracycline
0.07 – 1.34(1) Surface water USA
0.34(2) Natural water USA
up to 0.34(3) Surface water UK
0.5(4) Water UK
71.7(1) Runoff England
8.6 (µg/kg) (4) Soil UK
27 (µg/kg) (1) Soil North Germany
up to 29 (mg/kg) (1) Swine manure Austria
Tetracycline
0.11(2) Natural water USA
up to 0.11(3) Surface water UK
0.1(4) Water UK
1.2 a 4.2(2) Surface water Germany
(1) Regitano and Leal (2010); (2) Bila and Dezotti (2003); (3) Boxall et al. (2004); (4) Boxall et al. (2003).
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·	 Few of these molecules have log Kow > 4.0;
·	 Many of them behave as weak acids or basis, under-
going ionization in the pH conditions found in the 
environment;
·	 Many antibiotics are readily metabolized to more 
polar products, as conjugates;
·	 The concentrations found in the environment are 
low;
·	 There are no practical observations suggesting their 
bioaccumulation in natural conditions.
According to the information submitted, the 
potential for bioaccumulation of antibiotics in the 
environment is minimal.
Only when the concentration remains high for a long 
period of time, there is excessive accumulation and may 
develop arthropathy, nephropathy, changes in the central 
nervous system defects in spermatogenesis, mutagenicity 
and possible photosensitivity in humans (Kummerer et al., 
2000; Reyes et al., 2006).
Cumulative effects of chlortetracycline in plant 
tissue of cabbage, corn and green onions grown in soil 
fertilized with contaminated manure are reported by 
Kumar et al. (2005). Concentrations detected in these 
plants were in the order of 2-17 ng/g.
Boonsaner and Hawker (2012) studied the 
accumulation of tetracyclines in rice through the diffusion 
from aqueous solutions to the roots. They observed that 
the dissemination within the plant tissue is directly related 
to the hydrophobicity of the molecule. For concentrations 
of tetracycline of up to 50 mg/L, during 15 days, those 
authors did not observe dissemination of tetracycline to 
plant tissue remaining in the roots, and not caused changes 
in plant development.
Yang et al. (2013) evaluated the influence of 
tetracycline on the cyanobacteria Microcystis aeruginosa 
and chlorophycea Selenastrum capricornutum, abundant 
in aquatic systems, and observed that tetracycline has 
toxic effect especially on S. capricornutum because, in a 
first contact, inhibited the rate of biomass production of 
20-75% for tetracycline concentrations of 0.2-5.0 mg/L.
The sources of resistance plasmids in bacteria are 
old, for example in a study of Psychrobacter psychrophilus 
isolated from a pellet of frozen ground dated 25000-35000 
years, found a tetracycline resistance plasmid, consistent 
with markers found resistance in bacteria of clinical 
interest current (Petrova et al., 2009).
Resistant bacteria are generated by natural selection, 
genetic exchange between soil bacteria and those present 
in the feces of animals or between antibiotic-producing 
organisms (Pereira et al., 2012). In addition to DNA, 
the mechanisms of transposition and plasmid transfer, 
transduction for tetracycline resistance have been found in 
bacteriophage Salmonella spp. (Zhang and Lejeune, 2007).
The direct introduction of resistant microorganisms, 
from feces of animals treated with antibiotics, seems to 
be more important to the strength of the induction due 
to the presence of antibiotic residues in the environment 
(Thiele-Bruhn, 2003; Regitano and Leal, 2010). Esiobu et 
al., (2002) isolated a bacteria from a garden fertilized with 
dairy cattle, which had a frequency resistance of the order 
of 70% to ampicillin, penicillin, tetracycline, streptomycin 
and vancomycin.
TREATMENT AND DEGRADATION PRO-
DUCTS
When exposed to the environment, antibiotics 
suffer oxidative degradation. The products resulting from 
oxidation of tetracyclines may be even more toxic than the 
parent compound against bacteria commonly found in the 
environment (Boxall, 2004; Khetan, Collins, 2007).
Photolysis caused by solar irradiation has been 
considered as one of the most important processes in the 
degradation of antibiotics in natural aquatic environment 
(Andreozzi et al., 2003). This natural photolysis is 
significant for the degradation of the antibiotics mainly 
due to the presence of dissolved organic matter (DOM) and 
nitrate in natural aquatic environments, that can influence 
the photocatalytic reaction (Andreozzi et al., 2003; Zhan 
et al., 2006).
The photolysis of antibiotics by solar radiation in 
the environment can occur in two ways (Andreozzi et al., 
2003): direct, through the absorption of radiation by the 
drug molecule; indirectly, through the photosensibilisation 
of the molecule by natural components, such as nitrate and 
humic acids, which under solar irradiation can generate 
strong oxidizing species such as hydroxyl radicals and 
Singlet oxygen.
Degradation through solar photolysis can be 
influenced by the concentration of humic acid which 
absorbs the radiation and prevents the radiation to reach 
the other organic molecules (e.g. antibiotics). Another 
factor to be considered is the light incidence that depends 
on the latitude and season (Andreozzi et al., 2003).
Investigating the removal of several drugs present in 
urban and rural wastewater, several works have appeared 
in recent years in scientific publications, demonstrating 
the relevance of the subject.
In the case of tetracyclines, while passing through 
WWTPs, chemical modification may occur by hydrolysis, 
biodegradation or adsorption in the sludge. Some authors 
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claim that adsorption should be the main factor in 
removing antibiotics, which accumulate in the process 
and are not eliminated (Khan, Ongerth, 2004; Gartiser 
et al., 2007). Khan and Ongerth (2004) evaluated the 
half-life of several drugs during the passage of WWTPs 
in Australia. They determined that doxycycline had half-
life of 52 hours in an activated sludge process operating 
with suspended solids concentration of 2000 mg/L. Those 
authors determined that 5% of the drugs were adsorbed 
onto the sludge and 22% were biodegraded. 
Ghosh et al. (2009) studied five antibiotics 
(clarithromycin, enrofloxacin, sulfamethoxazole, 
tetracycline, trimethoprim) to assess their action on 
the bacteria responsible for oxidation of ammonia and 
observed that for concentrations lower than 0.05 mg/L 
these drugs, individually, had no significant effect on the 
bacteria.
Jia et al. (2009) studied the oxytetracycline (OTC) 
and tetracycline (TC) and its degradation products, 
4-epitetracycline (ETC), 4-epioxytetracycline (EOTC), 
isochlortetracycline (ICTC), anhydrotetracycline (ATC) 
and 4-epianhydrochlortetracycline (EACTC). Those 
authors evaluated the concentrations present in the 
influent, effluent and in the river, receiving the treated 
effluent, in the city of Beijing, China. The results are 
shown in Table V.
The presence of tetracyclines in effluents from 
various sources has stimulated many studies of new 
processes for the treatment of tetracyclines. Several studies 
address the mechanisms of degradation with various 
processes and the identification of products resulting from 
this degradation. However, most of the oxidation processes 
are based on the generation of hydroxyl radicals (Fatta et 
al., 2011).
The hydroxyl radical reacts with tetracycline mainly 
by electrophilic addition, forming organic radicals, but due 
to the complexity of the molecule, the stability of organic 
radical formed, the number of hydrogen atoms (positions 
of attack), the steric effects and the electronegativity 
of substituents, often radical reaction occurs with the 
substituent of the molecule and not with the aromatic ring 
(Pignatello et al., 2006).
Gujarathi et al. (2005) evaluated the use of 
Myriophyllum aquaticum and Pistia stratiotes for 
phytoremediation of effluents containing tetracycline 
and oxytetracycline. They concluded that the antibiotic 
molecules are degraded by enzymes present in the roots 
of these plants and observed almost complete degradation 
until 6 days after insertion of P. stratiotes and 15 days 
with M. aquaticum. The concentration of the antibiotics 
decreased with increasing initial concentration, which 
suggests that the modifying compound (catalytic enzyme) 
present in the roots can be in limited concentrations.
Ikehata et al. (2006) studied the photocatalytic 
degradation of tetracycline by TiO2 and obtained an almost 
complete conversion of 50 mg/L tetracycline treatment 
in two hours and about 90% of the Total Organic Carbon 
(TOC) was removed in 6 h.
Reyes et al. (2006) compared the efficiency of 
the removal of tetracycline in aqueous suspensions of 
TiO2 irradiated with three different light sources: a UV 
lamp, natural solar light and a UV-A lamp. No significant 
degradation observed when the irradiation was performed 
in the absence of TiO2. It was observed 50% degradation 
of the drug in the presence of 0.5 g/L of TiO2 in times of 
10, 20 and 120 minutes for the UV lamp, natural solar light 
and UV-A lamp, respectively. However, all the residues 
obtained through the 3 different treatments retained their 
bactericidal activity.
Jiao et al. (2008) studied the photocatalytic 
degradation of tetracycline and the toxicity of its 
degradation products which had molar mass (m/z) equal 
to 398 and 413. The naphthol of the tetracycline ring 
remained intact during photolysis and toxicity of the 
compounds of photolysis using V. fischeri showed that 
toxicity increased with irradiation.
TABLE V - Average concentrations of tetracycline and its byproducts detected in STPs and rivers (Jia et al., 2009)
Compound Inffluent (ng/L) Effluent (ng/L) River (ng/L)
OTC 72.5 3.8 2.2
TC 16.5 1.9 2.1
ETC 5.9 < BLD* < BLD*
EOTC 8.5 < BLD* < BLD*
ICTC 9.5 6.8 <BLD*
ATC 5.7 <BLD* <BLD*
EACTC 25.3 7.6 <BLD*
*<BLD = below limit of detection
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Sunaric et al. (2009) studied the oxidation of 
doxycycline with hydrogen peroxide using the copper 
ion as catalyst. Those authors compare the results 
of the residual concentration of drug obtained by 
spectrophotometry with those obtained by HPLC, showing 
relative standard deviation not exceeding 3.80%.
Jeong et al. (2010) studied the mechanism of 
oxidation by hydroxyl radicals of four antibiotics from 
the class of tetracyclines (tetracycline, chlortetracycline, 
oxytetracycline and doxycycline). The radicals were 
generated by irradiating the medium with gamma 
irradiation and pulse radiolysis of electrons which causes 
the breaking of the water molecule into hydroxyl radicals. 
They observed that the effectiveness of hydroxyl radical 
for the four tetracyclines ranged from 32% to 60%, 
whereas for aqueous free electrons (e-aq) the efficiency was 
of 15-29%, except for chlortetracycline, which it was 97%.
Rivas et al. (2011) studied the adsorption of 
doxycycline on charcoal, photolysis with UV-C and 
ozonation at concentrations of 5x10-5 M. In the process 
of adsorption on active carbon they obtained a reduction 
of 60 to 85% of TOC but with significant reduction in 
the efficiency with the reuse; 20% reduction of the initial 
concentration for 2h photolysis UV-C, but no reduction of 
TOC; instantly total degradation of the doxycycline with a 
60% reduction in TOC for the treatment with ozone. The 
combination of these 3 processes showed a 70% reduction 
of TOC.
Yuan et al. (2011) studied the degradation of 
oxytetracycline, doxycycline and ciprofloxacin with UV 
radiation and hydrogen peroxide associated with UV in 
water samples from different origins (ultrapure water, 
surface water, drinking water and effluent from WWTPs). 
They evaluated the toxicity of the degradation products by 
cultures of Vibrio fischer and observed that after treatment 
with UV no significant reduction in toxicity. For the 
treatment with UV/H2O2 the toxicity initially increased 
and then decreased forming nontoxic products. 
Godos et al. (2012) studied in pilot scale the 
biosorption and photodegradation of tetracycline in high 
FIGURE 4 - Products of photocatalytic degradation of tetracycline (Adapted from Mboula et al., 2012).
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FIGURE 5 – Degradation products of tetracycline through  direct photolysis,  photocatalysis with TiO2 and  photocatalysis 
with Sr-Bi2O3 (adapted from Niu et al., 2013).
rate algal ponds (HRAPs) with synthetic sewage from 
livestock. Those authors found that in HRAPs the process 
of photodegradation and biosorption of tetracycline are 
significant and that this type of treatment enables the 
removal of up to 69% of tetracycline and its degradation 
products, depending on the concentration of biomass. 
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Mboula et al. (2012) studied the degradation of 
the tetracycline with a heterogeneous photocatalytic 
process with TiO2/UV, focusing on the determination of 
biodegradability, toxicity and identification of the products 
formed during the photocatalytic treatment. They observed 
a 24% reduction in the concentration of the dissolved 
organic carbon, and reduced toxicity in Pseudomonas 
aeruginosa and the non-biodegradability through the 
Sturm test. The study of the by-products by HPLC-ESI (+) 
-MS/MS showed that the tetracycline ring is not opened, 
and thus the structure of the byproducts is not so different 
from the starting material, as shown in Figure 4.
Niu et al. (2013) studied the photodegradation 
of tetracycline in aqueous (5-50 mg/L) for 3 different 
methods: direct photodegradation, photocatalysis with TiO2 
and photocatalysis with Sr-Bi2O3. They used as a radiation 
source a Xenon lamp to simulate solar radiation and with 
filter that allowed the passage of only the wavelengths of 
visible light (λ ≥ 420nm). Those authors determined that 
the photocatalysis with Sr-Bi2O3 eliminated 91.2% of the 
initial tetracycline, photocatalysis with TiO2 80% and 
direct photolysis 70%, after 120 minutes run. Based on 
the analytical results of photodegradation products they 
proposed some degradation mechanisms of tetracycline, 
shown in Figure 5.
CONCLUDING REMARKS
This paper presents multiple aspects that comprise 
the study of tetracycline, ranging from production, use, 
chemical reactions, treatment, environmental impact and 
increasing bacterial resistance. Given the importance 
of this family of antibiotics in the treatment of various 
illnesses, their indiscriminate use and the general 
indifference in the disposal of medicines, studies for 
elimination and awareness should have greater focus by 
the scientific community. Little information has been 
found about the environmental impact of tetracycline; 
however show alarming situations of bacterial resistance 
and the presence of these drugs in drinking water.
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